Vildagliptin, a DPP-4 inhibitor for the twice-daily treatment of type 2 diabetes mellitus with or without metformin.

First published in Expert Opinion on Pharmacotherapy on 2014 Jun.Expert Opin Pharmacother. 2014 Jun;15(9):1299-313. doi: 10.1517/14656566.2014.920009 Authors: Forst T, Bramlage...
Read Article

Anti-diabetic treatment regulates pro-fibrotic TGF-β serum levels in type 2 diabetics.

First published in Diabetology & Metabolic Syndrome on 2013 Aug.Diabetol Metab Syndr. 2013 Aug 31;5(1):48. doi: 10.1186/1758-5996-5-48. Authors: Pscherer S,...
Read Article